2nd Quarter - Report

CAPITOL SOLUTIONS for AMGEN USA

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement and coverage issues

LobbyistCovered position, as disclosed
SARAH CURTIS Legislative Assistant, Rep. Strickland
DANIEL C TATE Legislative Director, Rep. W.J. Billy Tauzin

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R. 1956, To amend the Public Health Service Act to provide for the approval of similar biological products H.R. 1038, To provide for the licensing of comparable and interchangeable biological products H.R. 5629, To establish a pathway for licensure of biosimilar biological products

LobbyistCovered position, as disclosed
SARAH CURTIS Legislative Assistant, Rep. Strickland
DANIEL C TATE Legislative Director, Rep. W.J. Billy Tauzin

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5629 (110th), H.R. 1956 (110th), H.R. 1038 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.